骨愈康促进骨折愈合疗效与安全性的系统评价与Meta分析
该系统评价与Meta分析检索至2023年8月25日的权威数据库,纳入13项随机对照试验共1123例骨折患者,评估骨愈康(Osteoking)对骨折愈合的疗效与安全性。结果显示骨愈康组较对照组缩短骨折愈合时间、提高愈合率、减少肿胀消退时间和瘀斑消退时间并改善骨代谢,未报告严重不良反应;但结果不支持其在所有骨折部位提高愈合率或减轻疼痛。
要点
- 骨愈康可缩短骨折愈合时间、减少肿胀与瘀斑消退时间。
- 骨愈康组未报告严重不良反应,轻度副作用无需治疗可缓解。
- 不支持骨愈康在所有骨折部位提高愈合率或减轻疼痛。
核心结论
- 骨愈康治疗对加速骨折愈合、减轻肿胀、消除瘀斑和改善骨代谢有益且安全。
- Meta分析结果不支持骨愈康在所有骨折部位提高骨折愈合率或减轻所有骨折部位的疼痛。
研究设计与样本
- 系统评价与Meta分析,检索权威数据库至2023年8月25日。
- 纳入13项随机对照试验,共1123例骨折患者。
- 使用Cochrane工具评估偏倚风险,采用Review Manager 5.4软件进行Meta分析。
主要发现
- 与对照组相比,骨愈康组骨折愈合时间缩短。
- 骨愈康组骨折愈合率提高。
- 骨愈康组肿胀消退时间和瘀斑消退时间减少。
- 骨愈康组骨代谢改善。
- 纳入研究未报告与骨愈康使用相关的严重副作用,轻度副作用未经治疗自行缓解。
临床怎么用
- 骨愈康可用于加速骨折愈合、减轻肿胀和消除瘀斑。
- 骨愈康改善骨代谢,且未报告严重不良反应。
- 不应期望骨愈康在所有骨折部位均提高愈合率或减轻疼痛。
局限性
- Meta分析结果不支持骨愈康在所有骨折部位提高骨折愈合率或减轻所有骨折部位疼痛。
- 需要进一步原创、高质量研究验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoking (OK) is prescribed in traditional Chinese medicine to accelerate fracture healing. Although some studies suggest the potential efficacy of OK for fracture healing, the evidence remains inconclusive. AIM: To systematically evaluate the safety of OK and its effect on fracture healing. METHODS: Relevant authoritative databases were searched until 25 August 2023. Randomized controlled trials (RCTs) of patients with fractures treated with Osteoking were included. We evaluated the risk of bias using the Cochrane tool and performed a meta-analysis using the Review Manager 5.4 software package. RESULTS: 13 studies involving 1123 participants were included. This meta-analysis showed that compared with observations in the control group, the OK group showed a shortened fracture healing time, increased fracture healing rate, reduced swelling regression time and ecchymosis regression time, and improved bone metabolism. In addition, the included studies did not report any serious side effects associated with the use of OK, and the mild side effects resolved without treatment. CONCLUSION: OK therapy is beneficial and safe for accelerating fracture healing, reducing swelling, eliminating ecchymosis, and improving bone metabolism. However, the meta-analysis results do not support OK treatment for improving the fracture healing rate at all fracture sites and reducing pain across all fracture sites. Further original, high-quality studies are needed to validate these findings. UNLABELLED: Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=452430, identifier CRD42023452430.
引用
- Zhang L, Kuang H, Zhang Z, et al. Efficacy and safety of Osteoking on fracture healing: a systematic review and meta-analysis. Front Pharmacol. 2024. PMID: 38915474. doi:10.3389/fphar.2024.1363421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。